Antimicrobial prescribing: delafloxacin for community-acquired pneumonia Evidence Summary [ES37], NICE (published 10th August 2021)

Review of delafloxacin, a fluoroquinolone antibiotic available as an injection or tablet, covers the strengths and limitations of the efficacy and safety data from the pivotal RCT, where it was found to be non-inferior to moxifloxacin for community-acquired bacterial pneumonia
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news